Pfizer's (PFE) and Bristol-Myers Squibb's (BMY) Eliquis blood thinner cut the risk of clots in...

This news story has 5 comments:

Register or Login to rate comments »

blueice Comments (2477)
 
So the committee of ten, needs another six years while thousands die...

Thank you, FDA...
9 Dec 2012, 01:27 PM Reply Like

Hellz Comments (161)
 
It's not like it's the only blood thinner drug
9 Dec 2012, 04:46 PM Reply Like

blueice Comments (2477)
 
HELLZ, any drug that has an efficacy of 81% is considered by many as a miracle drug...

Of course, the FDA approval prodigal is so archaic, that in the process thousand of patients die awaiting their anointment...

For the sake of saving a few, they kill hundreds or thousands...

Government at its best, Hellz...
9 Dec 2012, 05:27 PM Reply Like

RREICHMAN Comment (1)
 
Note the efficacy is against placebo, NOT any of the other methods of anticoagulation (blood thinning) -- this is essentially a worthless study.
Yes, treatment (thinning blood in at risk patients) is better than no treatement -- DUH!!
Until there are head to head trials with Warfarin (coumadin) or the other anticooagulants (Pradexa, Xarelto, aprixiban, etc.) this study is close to meaningless, and at best a Phase I study demonstrating "proof of concept" equivalent.

Also suspect this study was not done in US or EU, since no IRB would approve the placebo arm of the study in "at-risk" patients.
9 Dec 2012, 08:32 PM Reply Like

blueice Comments (2477)
 
See page two, Reichman...It is standard FDA operating procedure..

But you are correct that it is simply stage one of testing and I gave it too much credit...

http://bit.ly/TOEP21
10 Dec 2012, 02:17 AM Reply Like